|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61M 5/28 | (2006.01) | ||
| A61M 5/31 | (2006.01) | ||
| A61M 5/315 | (2006.01) |
| (11) | Number of the document | 2869813 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13701276.1 |
| Date of filing the European patent application | 2013-01-25 | |
| (97) | Date of publication of the European application | 2015-05-13 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-21 |
| (46) | Date of publication of the claims translation | 2019-03-12 |
| (86) | Number | PCT/EP2013/051491 |
| Date | 2013-01-25 |
| (87) | Number | WO 2014/005728 |
| Date | 2014-01-09 |
| (30) | Number | Date | Country code |
| 12174860 | 2012-07-03 | EP | |
| 12189649 | 2012-10-23 | EP | |
| 202012011016 U | 2012-11-16 | DE | |
| 2012101677 | 2012-11-16 | AU | |
| 2012101678 | 2012-11-16 | AU | |
| 202012011260 U | 2012-11-23 | DE | |
| 202012011259 U | 2012-11-23 | DE | |
| 12195360 | 2012-12-03 | EP | |
| 202013000688 U | 2013-01-23 | DE | |
| 2013100071 | 2013-01-23 | AU | |
| 2013100070 | 2013-01-23 | AU |
| (72) |
SIGG, Juergen, CH
ROYER, Christophe, CH
BRYANT, Andrew Mark, CH
BUETTGEN, Heinrich Martin, CH
PICCI, Marie, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Otilija KLIMAITIENĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Švirkštas |
| SYRINGE |
| Payment date | Validity (years) | Amount | |
| 2021-12-30 | 10 | 231.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2022-07-18 |